Aripiprazole Adjunctive to Antidepressant Therapy Response

被引:0
|
作者
Yager, Joel [1 ]
Gelenberg, Alan J. [2 ]
Fochtmann, Laura J. [3 ]
机构
[1] APA Steering Comm Practice Guidelines, Denver, CO USA
[2] APA Work Grp Major Depress Disorder, Hershey, PA USA
[3] APA Practice Guidelines, Stony Brook, NY USA
来源
AMERICAN JOURNAL OF PSYCHIATRY | 2011年 / 168卷 / 02期
关键词
D O I
10.1176/appi.ajp.2010.10101515r
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
引用
收藏
页码:211 / 211
页数:1
相关论文
共 50 条
  • [41] Clinical usage of adjunctive aripiprazole in patients with bipolar disorders
    Chang, J. S.
    Ha, K.
    Moon, E.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 124 - 125
  • [42] Antidepressant-Induced Sweating Alleviated by Aripiprazole
    Lu, Brett Y.
    Cullen, Chandra E.
    Eide, Carla E.
    Williams, Cynthia C.
    Apfeldorf, William J.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2008, 28 (06) : 710 - 711
  • [43] Adjunctive aripiprazole for bupropion-resistant major depression
    Sokolski, Kenneth N.
    ANNALS OF PHARMACOTHERAPY, 2008, 42 (7-8) : 1124 - 1129
  • [44] The Effectiveness and Safety of Adjunctive Aripiprazole in Taiwanese Patients With Antidepressant-Refractory Major Depressive Disorder A Prospective, Open-Label Trial
    Chen, Shaw-Ji
    Hsiao, Yi-Lin
    Shen, Tsu-Wang
    Chen, Shao-Tsu
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2012, 32 (01) : 56 - 60
  • [45] Efficacy and tolerability of open-label aripiprazole augmentation of antidepressant therapy in major depressive disorder
    Shin, D.
    Hong, S.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S300 - S300
  • [46] Adjunctive treatment with aripiprazole for risperidone-induced hyperprolactinemia
    Ranjbar, Fatemeh
    Sadeghi-Bazargani, Homayoun
    Khams, Parisa Niari
    Arfaie, Asghar
    Salari, Azim
    Farahbakhsh, Mostafa
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2015, 11 : 549 - 555
  • [47] The pharmacokinetics of standard antidepressants with aripiprazole as adjunctive therapy: studies in healthy subjects and in patients with major depressive disorder
    Boulton, D. W.
    Balch, A. H.
    Royzman, K.
    Patel, C. G.
    Berman, R. M.
    Mallikaarjun, S.
    Reeves, R. A.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2010, 24 (04) : 537 - 546
  • [48] Antidepressant response to aripiprazole augmentation associated with enhanced FDOPA utilization in striatum: A preliminary PET study
    Conway, Charles R.
    Chibnall, John T.
    Cumming, Paul
    Mintun, Mark A.
    Gebara, Marie Anne I.
    Perantie, Dana C.
    Price, Joseph L.
    Cornell, Martha E.
    McConathy, Jonathan E.
    Gangwani, Sunil
    Sheline, Yvette I.
    PSYCHIATRY RESEARCH-NEUROIMAGING, 2014, 221 (03) : 231 - 239
  • [49] TRH RESPONSE AS SCREENING FOR SPECIFIC ANTIDEPRESSANT THERAPY
    PUHRINGER, W
    WIRZJUSTICE, A
    HOLE, G
    LANCET, 1975, 1 (7920): : 1344 - 1345
  • [50] The delay in response to antidepressant therapy: A window of opportunity?
    Malhi, Gin S.
    Bell, Erica
    Morris, Grace
    Hamilton, Amber
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2020, 54 (02): : 127 - 129